You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 29, 2026

List of Excipients in API bromfenac


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing bromfenac

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Sun Pharmaceutical Industries Inc BROMSITE bromfenac 49708-754 ANHYDROUS CITRIC ACID
Sun Pharmaceutical Industries Inc BROMSITE bromfenac 49708-754 BENZALKONIUM CHLORIDE
Sun Pharmaceutical Industries Inc BROMSITE bromfenac 49708-754 BORIC ACID
Sun Pharmaceutical Industries Inc BROMSITE bromfenac 49708-754 EDETATE DISODIUM
Sun Pharmaceutical Industries Inc BROMSITE bromfenac 49708-754 POLOXAMER 407
Sun Pharmaceutical Industries Inc BROMSITE bromfenac 49708-754 POLYCARBOPHIL
Sun Pharmaceutical Industries Inc BROMSITE bromfenac 49708-754 SODIUM BORATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing bromfenac

Company Ingredient NDC Excipient
Alembic Pharmaceuticals Limited bromfenac 46708-508 BORIC ACID
Alembic Pharmaceuticals Limited bromfenac 46708-508 EDETATE DISODIUM
Alembic Pharmaceuticals Limited bromfenac 46708-508 POLYSORBATE 80
Alembic Pharmaceuticals Limited bromfenac 46708-508 POVIDONE K30
Alembic Pharmaceuticals Limited bromfenac 46708-508 SODIUM BORATE
Alembic Pharmaceuticals Limited bromfenac 46708-508 SODIUM HYDROXIDE
Alembic Pharmaceuticals Limited bromfenac 46708-508 SODIUM SULFATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for bromfenac

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BORIC ACID

Excipient focus: EDETATE DISODIUM

Excipient focus: POLOXAMER 407

Excipient focus: POLYCARBOPHIL

Excipient focus: POLYSORBATE 80

bromfenac drug variants not containing POLYSORBATE 80

Company Ingredient NDC
Sun Pharmaceutical Industries Inc bromfenac 49708-754
Sun Pharmaceutical Industries Inc bromfenac 49708-755
Amneal Pharmaceuticals NY LLC bromfenac 60219-1526
Lupin Pharmaceuticals Inc bromfenac 68180-434
Bausch & Lomb Incorporated bromfenac sodium 24208-602
Alembic Pharmaceuticals Limited bromfenac sodium 46708-583
Apotex Corp bromfenac sodium 60505-1006
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POVIDONE

bromfenac drug variants containing POVIDONE

Company Ingredient NDC
Physicians Total Care Inc bromfenac 54868-6301
Amneal Pharmaceuticals NY LLC bromfenac 60219-1526
Lupin Pharmaceuticals Inc bromfenac 68180-436
Bausch & Lomb Incorporated bromfenac sodium 24208-602
Alembic Pharmaceuticals Limited bromfenac sodium 46708-583
Physicians Total Care Inc bromfenac sodium 54868-6343
Apotex Corp bromfenac sodium 60505-1006
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: SODIUM BORATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM SULFATE

Excipient focus: SODIUM SULFITE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: TYLOXAPOL

bromfenac drug variants containing TYLOXAPOL

Company Ingredient NDC
Amneal Pharmaceuticals NY LLC bromfenac 60219-1526
Bausch & Lomb Incorporated bromfenac sodium 24208-602
Alembic Pharmaceuticals Limited bromfenac sodium 46708-583
Apotex Corp bromfenac sodium 60505-1006
Alembic Pharmaceuticals Inc bromfenac sodium 62332-583
Lupin Pharmaceuticals Inc bromfenac sodium 68180-433
Dr Reddy's Laboratories Inc bromfenac sodium 75907-093
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links